This inventor holds 5 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: University of Utah Research Foundation, Ballard Spahr LLP. Active years: 2019-2023.
Company Filing History:
Years Active: 2019-2023
Title: The Innovations of Andrew S. Weyrich
Introduction
Andrew S. Weyrich is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory disorders and cancer. With a total of 5 patents, his work has the potential to impact many lives.
Latest Patents
Weyrich's latest patents focus on methods for the treatment and prophylaxis against inflammatory disorders. One of his key inventions is an isolated and purified peptide known as the neonatal NET-inhibitory Factor (nNIF). This invention includes methods of treatment that involve administering NET-inhibitory peptides (NIPs), which may include nNIF and its analogs. Additionally, he has developed methods for inhibiting metastasis in cancer patients, showcasing the versatility and importance of his research.
Career Highlights
Throughout his career, Weyrich has worked with esteemed organizations such as the University of Utah Research Foundation and Ballard Spahr LLP. His experience in these institutions has allowed him to advance his research and contribute to the scientific community effectively.
Collaborations
Weyrich has collaborated with notable colleagues, including Christian Con Yost and Guy A. Zimmerman. These partnerships have further enriched his research and innovation efforts.
Conclusion
Andrew S. Weyrich's contributions to medical research through his patents and collaborations highlight his dedication to improving health outcomes. His work continues to pave the way for advancements in the treatment of inflammatory disorders and cancer.